Farbenfabriken Bayer A G v Bayer Pharma Pty Ltd

The parties to this dispute were Farbenfabriken Bayer A G and Bayer Pharma Pty Ltd. The core of the disagreement concerned the use of the name "Bayer" in relation to pharmaceutical products. The case was heard by the High Court of Australia.

The central legal issue before the High Court was whether the respondent, Bayer Pharma Pty Ltd, had infringed the appellant's trade mark rights by using the name "Bayer" in connection with its pharmaceutical preparations. This involved determining the scope of the appellant's registered trade mark and whether the respondent's use of the name constituted a deceptive or confusing use in the marketplace.

The Court considered the evidence of the appellant's long-standing use of the "Bayer" mark in Australia and its established reputation in the pharmaceutical industry. It was held that the respondent's adoption and use of the "Bayer" name for its pharmaceutical products was likely to deceive or cause confusion among consumers, leading to an infringement of the appellant's trade mark rights. The Court applied principles of trade mark law relating to the likelihood of deception and the protection of established goodwill.

The High Court found in favour of the appellant, Farbenfabriken Bayer A G, and ordered that the respondent, Bayer Pharma Pty Ltd, be restrained from using the name "Bayer" in connection with its pharmaceutical products.